regramostim: Clinical Trials

2 trials of regramostim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Recruiting 1

Follow regramostim: new trials by email Literature Review of regramostim trials Research Report on regramostim

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
Molgramostim - Autoimmune Pulmonary Alveolar Proteinosis
Phase 3RecruitingSavara Inc.52025-10-222026-02-19
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Molgramostim, Placebo, Molgramostim Open-label - Autoimmune Pulmonary Alveolar Proteinosis
Phase 3Active not recruitingSavara Inc.1642021-05-192026-11-18

Conditions studied

Pulmonary Alveolar Proteinosis, Acquired (2)  ·  Pulmonary Alveolar Proteinosis (1)

Sponsors

Savara Inc. (2)

Countries

Germany (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Greece (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Romania (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Bruce Trapnell, MD (1)  ·  Matthias Griese, MD, (1)

Results publications

PMID 40834301